France vs Tuvalu: The number of people with susceptibility test result for rifampicin
France
17
in 2021
Tuvalu
19
in 2021
France rank
134th
Tuvalu rank
133rd
The number of people with susceptibility test result for rifampicin over time
- France
- Tuvalu
How they compare
Tuvalu currently reports 19 against 17 in France, a difference of 2.
That makes Tuvalu's figure about 1.1 times France's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was France ahead.
France ranks 134th and Tuvalu ranks 133rd of 155 countries.
France has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,801 | 14 | 1,787 | France |
| 2020s | 18.5 | 17 | 1.5 | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, France or Tuvalu?
- Tuvalu, at 19 against 17 in France as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between France and Tuvalu?
- 2, with Tuvalu ahead.
- How many years of comparable data are there for France and Tuvalu?
- 5 years are reported by both, from 2017 to 2021.
- How do France and Tuvalu rank globally for the number of people with susceptibility test result for rifampicin?
- France ranks 134th and Tuvalu ranks 133rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.